AI Science Tracker
EN

Shanghai General Hospital, Shanghai Jiao Tong University

1 discovery from 2026

Discoveries

Cross-center prediction of ICU-acquired weakness from early admission data

Source check: Source checked. Not independent scientific confirmation.

Finding: In three Shanghai medical centers, five models predicted ICU-acquired weakness among 535 critically ill patients using variables available within 48 hours of admission. External AUROC was 0.853 for SVM and 0.841 for logistic regression; tree-based models showed overfitting. Model-guided care and improved patient outcomes were not tested.

Technology: Logistic regression, random forest, SVM, CART and XGBoost trained on early ICU clinical variables

Publication: Peer-reviewed paper · Test context: prospective or independent check. Catalog categories, not an evidence grade.

AI contribution
Five predictive algorithms were trained with 10-fold cross-validated grid search on data available within 48 hours of admission; a six-predictor logistic model was also converted to a nomogram.
Test and result
Five machine-learning algorithms and logistic regression were compared in 395 internal-cohort patients and externally validated in 140 patients from two other centers. External AUROC was 0.853 for SVM and 0.841 for logistic regression; tree-based methods showed substantial performance attenuation consistent with overfitting.
Limitation / still unknown
The study did not test whether model-guided care reduces ICU-acquired weakness or improves recovery; prospective interventional evaluation is still needed.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13744720/ · https://pubmed.ncbi.nlm.nih.gov/43001150/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 4/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.